Tokyo, June 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057948) titled 'Safety Confirmation Study on Overdose of Supplement Containing Bee Larva in Healthy Subjects' on May 26
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponser:
Institute - Yamada Bee Company, Inc.
Condition:
Condition - Healthy Adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Intervention:
Interventions/Control_1 - Capsule-type supplement containing bee larva and trace amounts of royal jelly ingredients
Intake amount: 20 grains/day
Intake duration: 28 days
Elig...